Metabolically Healthy Obesity
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Obesity contributes to reduced life expectancy, impaired quality of life, and disabilities, mainly in those individuals who develop cardiovascular diseases, type 2 diabetes, osteoarthritis, and cancer. However, there is a large variation in the individual risk to developing obesity-associated comorbid diseases that cannot simply be explained by the extent of adiposity. Observations that a proportion of individuals with obesity have a significantly lower risk for cardiometabolic abnormalities led to the concept of metabolically healthy obesity (MHO). Although there is no clear definition, normal glucose and lipid metabolism parameters—in addition to the absence of hypertension—usually serve as criteria to diagnose MHO. Biological mechanisms underlying MHO lower amounts of ectopic fat (visceral and liver), and higher leg fat deposition, expandability of subcutaneous adipose tissue, preserved insulin sensitivity, and beta-cell function as well as better cardiorespiratory fitness compared to unhealthy obesity. Whereas the absence of metabolic abnormalities may reduce the risk of type 2 diabetes and cardiovascular diseases in metabolically healthy individuals compared to unhealthy individuals with obesity, it is still higher in comparison with healthy lean individuals. In addition, MHO seems to be a transient phenotype further justifying therapeutic weight loss attempts—even in this subgroup—which might not benefit from reducing body weight to the same extent as patients with unhealthy obesity. Metabolically healthy obesity represents a model to study mechanisms linking obesity to cardiometabolic complications. Metabolically healthy obesity should not be considered a safe condition, which does not require obesity treatment, but may guide decision-making for a personalized and risk-stratified obesity treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hyperplasia, referring to an increase in the number of adipocytes, is associated with an increase in subcutaneous fat volume and protective signals, and is associated with MHO (50).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
The cited source says what the claim attributes to it.
In the citing paper
“On the contrary, hypertrophic adipocytes, in which existing adipocytes enlarge, is associated with increased dysfunction and MUHO (50), which contributes to IR and subsequent T2D (52, 53).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 7×
“8 Endocrine Reviews, June 2020, 41(3):1–16 Blüher Metabolically Healthy Obesity sex hormones may play a role in the transition from MHO to MUO.”
BackgroundInfluentialSelf-citationThe global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Cited by
Items 501–600 of 999
He, F., Wan, G., & Chen, J. (2022) · Journal of Separation Science · doi:10.1002/jssc.202200541 · Cited by 5
Stafeev, I., Michurina, S. S., Agareva, M. Y., Zubkova, E., Sklyanik, I. A., Shestakova, E. A., Gavrilova, A., Sineokaya, M. S., Ratner, E. I., Menshikov, M. Y., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01317-1 · Cited by 5
“Nevertheless, not every case of obesity leads to T2DM onset, only 50% of obese individuals develop T2DM [6, 7].”
BackgroundWan, S., An, Y., Fan, W., Teng, F., & Jiang, Z. (2023) · Bioscience Reports · doi:10.1042/bsr20230501 · Cited by 6
Obesity vs. Metabolically Healthy Obesity in East Asia
Mathis, B. J., Tanaka, K., & Hiramatsu, Y. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020053 · Cited by 8
Genomics reveals eleven obesity endotypes with distinct biological and phenotypic signaturesPreprint
Kim, M. S., Song, M., Kim, H., Park, S., Shim, I., Lim, S., Kim, B., Chen, X., Sui, Y., Cho, S. M. J., et al. (2025) · medRxiv · doi:10.1101/2025.06.30.25330607 · Cited by 6
Research Progress of Metabolically Healthy Obesity and Inflammatory Factors
许, 虎. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141076 · Cited by 4
Egea, M. B., & Fernandes, S. S. (2025) · Plant Foods for Human Nutrition · doi:10.1007/s11130-025-01331-w · Cited by 4
“Furthermore, there is currently talk about the concept of BMI (calculated by the individual’s weight and height), indicating overweight and obesity, and biochemical parameters that indicate that the individual is metabolically healthy [61].”
Liu, M., Xu, Z., He, L., Xu, X., Cai, X., Guo, Y., Zhang, S., Xu, X., Xiong, Z., Zhuang, X., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16391 · Cited by 4
“15 Moreover, while clustering-based approaches to obesity classification provide some level of population segmentation, their clinical applicability remains limited.”
Soler, M. G., López, P. J. T., López‐González, Á. A., Paublini, H., Rifá, E. M.-A., Herrero, M. T. V., & Ramírez‐Manent, J. I. (2025) · Diabetology · doi:10.3390/diabetology6040032 · Cited by 7
Obesity Phenotypes Causally Affect Cardiac MRI Structure and Induced Non-ischaemic Cardiomyopathy
Peng, L., Zeng, T., Quan, E., Pan, S., Li, B., Wen, Z., Xiong, Z., & Zhao, Y. (2025) · Cardiac failure review · doi:10.15420/cfr.2024.26 · Cited by 4
Zahid, S., Peng, A. W., Razavi, A. C., Yao, Z., Blumenthal, R. S., & Blaha, M. J. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101281 · Cited by 6
González, S., Schiavone, M., Piñero, F., Melchiori, R. E., Brenzoni, N., García, G., Alarcón, P., Ferroni, F., Baratta, S., & Castellaro, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1607399 · Cited by 4
“While the number of studies on MHO has grown significantly in recent years (24–26), the field lacks consensus on several key issues, the most prominent of which is the definition of MHO.”
Yin, C.-Y., Zhang, H., Liu, L., Ban, X.-Y., Xu, T., Peng, G., Wang, C., Zhang, H., Han, X., Zheng, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-17358-7 · Cited by 5
Sepúlveda-Villegas, M., Panduro, A., Leal-Mercado, L., Cardenas-Benitez, J. P., Ojeda‐Granados, C., & Román, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1569342 · Cited by 5
Elevated uric acid levels link to a higher cardiometabolic risk profile in adolescents
Iorra, F. D. Q., Rodrigues, P. G., Barcelos, A. T., Cureau, F. V., & Schaan, B. D. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02798-9 · Cited by 5
Functional analysis of differentially expressed circular RNAs in sheep subcutaneous fat
Liu, T., Feng, H., Yousuf, S., Xie, L., & Miao, X. (2023) · BMC Genomics · doi:10.1186/s12864-023-09401-6 · Cited by 4
Dong, H., Guo, H., Du, J., Cheng, Y., Wang, D., Han, J., Yuan, Z., Yao, Z., An, R., Wu, X., et al. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00327-x · Cited by 4
“…lower content of ectopic fat (visceral and liver), better cardiorespiratory fitness, and maintenance of insulin sensitivity and beta cell function [20]; and it was reported that metabolically healthy obesity was associated with a lower risk of some adverse health outcomes, including major adverse…”
BackgroundHuang, J., Ramakrishnan, R., Liu, Q., Wang, C., Shen, S., Huang, M., Wei, X., Qiu, X., & He, J. (2024) · Pediatric Obesity · doi:10.1111/ijpo.13127 · Cited by 4
“10 Also, classifying obesity solely based on cardiometabolic outcomes might have limited benefits in terms of preventing these adverse outcomes.”
BackgroundHepşen, S., Gul, U., Bostan, H., Akhanlı, P., Sencar, M. E., Kızılgül, M., Ünsal, İ. Ö., & Çakal, E. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01598-0 · Cited by 6
“MHO is a recent nomenclature de fi ning individuals with a BMI higher than 30 kg/m² but who are free from obesity-related comorbidities such as glucose metabolism impairments, hypertension, dyslipidemia, and coronary artery diseases [10].”
BackgroundInfluentialThe Greater the Number of Altered Eating Behaviors in Obesity, the More Severe the Psychopathology
Carbone, E. A., Rania, M., D’Onofrio, E., Quirino, D., de Filippis, R., Rotella, L., Aloi, M., Fiorentino, T. V., Murphy, R., & Segura‐Garcìa, C. (2024) · Nutrients · doi:10.3390/nu16244378 · Cited by 5
Huang, W. H., Xiao, Y.-S., ZOU, Y., Zhong, L.-Q., & Huang, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1526377 · Cited by 7
Li, J., Xu, X., Yu, Y., Sun, Y. B., Cai, L., Shen, W., Wang, B., Tan, X. W., Lu, Y., & Wang, N. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.1942 · Cited by 4
Tang, S.-Y., Wu, H., Liu, M., Li, J., Lu, Y., Cao, R.-L., Lu, G.-Q., & li, X. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01644-2 · Cited by 5
“These inflammatory cytokines are associated with reduced skeletal muscle mass and vis - ceral fat accumulation [ 8 , 9 ].”
Assessing the Contribution of Relative Macrophage Frequencies to Subcutaneous Adipose Tissue
Kalafati, M., Lenz, M., Ertaylan, G., Arts, I. C. W., Evelo, C. T., van Greevenbroek, M. M. J., Blaak, E. E., Adriaens, M. E., & Kutmon, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.675935 · Cited by 4
“Failure of adipocyte differentiation has been associated with reduced expandability of adipose tissue, contributing to adipose tissue inflammation, systemic inflammation, lipid overflow, and insulin resistance (8, 28, 29), while low numbers of adipocytes may be associated with impaired metabolic health (30).”
BackgroundXu, Q., Zhang, J., Han, H., Chen, N., Lai, F., Liu, Y., Huang, C., Lin, M., Zhang, W., Wang, S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057820 · Cited by 4
Long-range chromosomal interactions increase and mark repressed gene expression during adipogenesis
Garske, K. M., Comenho, C., Pan, D. Z., Alvarez, M., Mohlke, K. L., Laakso, M., Pietiläinen, K. H., & Pajukanta, P. (2022) · Epigenetics · doi:10.1080/15592294.2022.2088145 · Cited by 4
“An alternative healthier mechanism is hyperplasia, in which preadipocytes differentiate to create new adipocytes to store the excess fat [6].”
BackgroundAlmasi, M. H., Barzin, M., Mahdavi, M., Khalaj, A., Ebrahimi, D., Valizadeh, M., & Hosseinpanah, F. (2022) · World Journal of Surgery · doi:10.1007/s00268-022-06769-6 · Cited by 4
“postpone an indicated obesity treatment is under discussion [2].”
BackgroundKillian, A. C., Reed, R. D., McLeod, M. C., MacLennan, P. A., Kumar, V., Pittman, S. E., Maynor, A. G., Stanford, L. A., Baker, G. A., Schinstock, C. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276882 · Cited by 5
“Metabolically healthy obesity has been defined as a BMI � 30.0 kg/m 2 in the absence of any cardiometabolic abnormalities that comprise metabolic syndrome [38, 39].”
InfluentialSchinzari, F., Vizioli, G., Campia, U., Cardillo, C., & Tesauro, M. (2023) · Vascular Medicine · doi:10.1177/1358863x231161657 · Cited by 5
Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin
Kitamoto, T., & Accili, D. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0150 · Cited by 4
Hart, S. M., Keirns, B. H., Sciarrillo, C. M., Malin, S. K., Kurti, S. P., & Emerson, S. R. (2023) · European Journal of Applied Physiology · doi:10.1007/s00421-023-05344-8 · Cited by 4
Zhang, N., & Wang, G. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s431194 · Cited by 5
Manno, V., Minardi, V., Masocco, M., Cobellis, F., Minelli, G., & Greco, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1332076 · Cited by 5
Lin, I.-H., Yu, Y., Duong, T. V., Nien, S.-W., Tseng, I.-H., Wu, Y., Chiang, Y., Chiang, C.-Y., Chiu, C.-H., Wang, M.-H., et al. (2024) · Nutrients · doi:10.3390/nu16193344 · Cited by 4
Overgeneralization of autonomic defensive reactions in obesity
Manassero, E., Scarpina, F., Tagini, S., Concina, G., Scacchi, M., Pollo, A., Mauro, A., & Sacchetti, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-72439-3 · Cited by 6
“All participants were nonsmokers and free from gastrointestinal, cardiovascular, psychiatric, neurological, or metabolic disorders or any concurrent medical condition not related to obesity, following the clinical definition of ‘Metabolically Healthy Obesity’ 73 .”
Lee, J., Kim, W., Park, J. M., Huh, Y., Kim, J. H., Kim, Y. S., & Kang, S. Y. (2024) · Nutrients · doi:10.3390/nu16223833 · Cited by 5
Alhomaid, A., Chauhan, S., Katamreddy, Y., Sidhu, A., Sunkara, P., & Desai, R. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100168 · Cited by 4
Postelnicu, M. G., Stan, A. M., Adam, A. M., Gheorghe, C., Pârvu, C., Codreanu, C. M., Moraru, L., Iordan, D. A., & Onu, I. (2025) · Balneo and PRM Research Journal · doi:10.12680/balneo.2025.767 · Cited by 4
“Globally, the prevalence of overweight and obesity has almost tripled in adults and has increased considerably among children and adolescents from 4% in 1975 to 18% today in both developing and developed countries [18, 19, 20].”
Chen, Y., Wu, W., Cai, Z., Wu, K., Zheng, H., Fu, P., Wang, Y., Wang, X., Lan, Y., Chen, S., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1524786 · Cited by 7
“This aligns with the emerging concept of adaptive metabolically healthy obesity proposed by Blüher (15), wherein preserved metabolic parameters mask subclinical endothelial dysfunction.”
Association Between Nutrition Patterns and Metabolic and Psychological State Among Young Adults
Ortiz, G. G. R., Granero, R., Aranda, P., & Quezada, M. A. A. (2025) · European Eating Disorders Review · doi:10.1002/erv.3209 · Cited by 4
Evaluation of Type 2 Diabetes Risk in Individuals With or Without Metabolically Healthy Obesity
Samuelsson, M. G., López, P. J. T., López‐González, Á. A., Busquets-Cortés, C., de Hevia, J. O., & Ramírez‐Manent, J. I. (2025) · Biology · doi:10.3390/biology14060608 · Cited by 5
Renzi, G., Higos, R., Vlassakev, I., Bello, A. A., Omar‐Hmeadi, M., Hansen, M., Merabtene, F., Rouault, C., Hodek, O., Massier, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116489 · Cited by 7
Balcázar‐Hernández, L., Basurto, L., Apolinar, L. M., Vega-García, S., Basurto-Acevedo, N. E., Murillo, C. M., & Sánchez‐Arenas, R. (2021) · Metabolites · doi:10.3390/metabo11110771 · Cited by 6
“Currently, MHO has been defined as the absence of any metabolic disorder or cardiovascular disease (CVD), including type 2 diabetes, dyslipidemia, hypertension, and atherosclerotic cardiovascular disease in a person with obesity [9].”
BackgroundŞAHİN, T., & Tozcu, D. (2022) · International Journal of Science Letters · doi:10.38058/ijsl.1053393 · Cited by 5
Mun, H., & So, E. S. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100721 · Cited by 5
Hashem, A. M., Cifuentes, L., Calderón, G., Ricardo-Silgado, M. L., Gonzalez‐Izundegui, D., Campos, A., MCRAE, A. N., Franks, S., Hurtado, M. D., Burton, D. B., et al. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00108.2022 · Cited by 5
López-Gómez, S. A., González-López, B. S., Scougall‐Vilchis, R. J., Márquez-Corona, M. D. L., Minaya‐Sánchez, M., Navarrete-Hernández, J. D. J., de la Rosa-Santillana, R., Acuña-González, G. R., Pontigo‐Loyola, A. P., Villalobos-Rodelo, J. J., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010218 · Cited by 9
Wang, X., Zeng, Q., Ma, N., Peng, L., Liu, L., Hong, F., & Xu, Y. (2023) · Endocrine · doi:10.1007/s12020-023-03308-8 · Cited by 4
“According to previous results, compared to individuals with MUOO, those with MHOO tended to have a healthier lifestyle, a small amount of visceral fatness, less mass of liver ectopic fat deposition, and higher subcutaneous leg fat content [10, 13, 48].”
ResultSzczerbowska‐Boruchowska, M., Piana, K., Surówka, A. D., Czyżycki, M., Wróbel, P., Szymkowski, M., & Ziomber-Lisiak, A. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.122478 · Cited by 5
Cataldi, S., Aprile, M., Perfetto, C., Angot, B., Cormont, M., Ciccodicola, A., Tanti, J., & Costa, V. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151320 · Cited by 4
Vasylenko, O. O., & Tykhonova, T. M. (2022) · Actual problems of modern medicine · doi:10.26565/2617-409x-2022-9-08 · Cited by 6
Ben‐Shachar, M., Daniel, T., Wollman, A., Sharmila, G., Aviel‐Ronen, S., Pinhasov, A., & Rosenzweig, T. (2023) · Obesity · doi:10.1002/oby.23777 · Cited by 4
“However, a fraction of individuals with obesity deviate from this correlation, presenting a healthier metabolic phenotype than expected according to their body mass index [4, 23].”
BackgroundAberra, Y. T., Ma, L., Björkegren, J., & Civelek, M. (2023) · eLife · doi:10.7554/elife.79834 · Cited by 5
Zhu, R., Huttunen‐Lenz, M., Stratton, G., Handjieva‐Darlenska, T., Handjiev, S., Sundvall, J., Silvestre, M. P., Jalo, E., Pietiläinen, K. H., Adam, T. C., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01328-y · Cited by 8
“0 mmol·L for fasting plasma glucose) [5, 36].”
BackgroundInfluentialLiu, Y., Liu, X., Kuang, J., & Guan, H. (2023) · Obesity Facts · doi:10.1159/000533157 · Cited by 6
Vyas, A., Desai, R., Vasavada, A. M., Ghadge, N. M., Jain, A., Pandya, D., & Lavie, C. J. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01403-4 · Cited by 4
Ahn, H. J., Ishikawa, K. M., & Kim, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304785 · Cited by 7
“Individuals with metabolically healthy obesity are known to exhibit various favorable characteristics in terms of metabolism [3], despite being obese, and have a relatively lower cardiovascular risk compared to the metabolically unhealthy population [4].”
BackgroundMohany, K. M., Rugaie, O. A., Al‐Wutayd, O., Alsharidah, M. S., & Al‐Nafeesah, A. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11330 · Cited by 5
Fernández, L. P., Merino, M. J., Colmenarejo, G., Moreno‐Rubio, J., Pessolani, T. G., Reglero, G., Casado, E., Sereno, M., & de Molina, A. R. (2021) · Cancers · doi:10.3390/cancers13051112 · Cited by 4
Park, Y., Kim, H., Gil, T., Kim, H.-J., Jin, J., Cha, Y., & An, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27600 · Cited by 3
“Obesity leads to a decreased life expectancy of up to ~20 years due to increased mortality from non-communicable diseases, e.g. atherosclerotic cardiovascular diseases, type 2 diabetes, and certain types of cancer [1].”
BackgroundPuente-Ruiz, S. C., Ide, L., Schuller, J., Ben-Kraiem, A., Hoffmann, A., Ghosh, A., Noé, F., Wolfrum, C., Krause, K., Gericke, M. T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112819 · Cited by 4
Self-citationLiu, H., Xu, F., Zhang, M., Chen, X., Fan, H., & Hou, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112367 · Cited by 8
Huang, J., Zhang, X., Ramakrishnan, R., Chu, J., Lu, M., Shao, D., Qiu, X., & He, J. (2025) · Obesity Reviews · doi:10.1111/obr.70006 · Cited by 8
Mild Mitochondrial Uncoupling for True Ectopic Lipid Disposal
Lee, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167740 · Cited by 4
Zhang, F., de Bock, G. H., Landman, G. W. D., Zhang, Q., van der Vegt, B., & Sidorenkov, G. A. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02105-7 · Cited by 4
“It is estimated that nearly one-third of obese individuals are metabolically healthy, usually referring to normal glucose and lipid metabolism parameters in addition to the absence of hypertension [9, 10].”
Georgoulis, M., Grapsa, I., Arnaoutis, G., Bountziouka, V., Karachaliou, A., Saltaouras, G., Bathrellou, E., Yannakoulia, M., Dimitrakopoulos, G., & Kontogianni, M. D. (2025) · Obesity Reviews · doi:10.1111/obr.70014 · Cited by 7
Enver, E. Ö., Duygu, A., Vatansever, P., Yılmaz, B., & Akın, Y. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1631302 · Cited by 3
“These findings are consistent with the concept of MHO, a phenotype characterized by preserved insulin sensitivity and the absence of typical metabolic disturbances in the presence of excess adiposity (30, 31).”
CCL26 and CXCL12 preserve insulin-sensitizing macrophages in subcutaneous adipose tissue in obesity
Jeelani, I., da Cunha, F. F., Rohm, T. V., Nasamran, C. A., Wang, L., Moon, J.-S., Prakash, S., Oswari, J., Isaac, R., Murphy, C., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116450 · Cited by 5
Wang, R., Cao, L., Zhang, P., Chen, H., Zhong, Q., Sang, Z., Wu, C., & He, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02744-x · Cited by 4
“Furthermore, obesity phenotypes are dynamic, and long-term monitoring combined with personalized management may help reduce the risk of developing metabolic diseases [32].”
Ezzatvar, Y., López‐Gil, J. F., Sepulveda, R. A. Y., Almonacid, J. G. H., & García‐Hermoso, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1704277 · Cited by 5
“Finally, the presence of other health conditions, such as obesity and hypertension, may counteract the bene fi ts of diabetes management, limiting the positive effects on life expectancy (69).”
Minerva, F. (2025) · Bioethics · doi:10.1111/bioe.70068 · Cited by 8
Current Knowledge of Obesity‐Related Vascular Injury
Liu, J., & Yang, D. (2025) · Obesity Reviews · doi:10.1111/obr.70080 · Cited by 5
“Although this subgroup is considered to have no overt cardiometabolic abnormalities, their risk of cardiometabolic disease remains higher than that of metabolically healthy lean individuals, warranting weight-loss interventions [7].”
Huang, S.-S., Li, S.-P., Xie, C.-Y., Qiu, J.-Y., Wang, P. Q., Zhang, J., Cheng, C.-Y., Ding, C., Ma, Y.-J., Ding, D., et al. (2026) · European journal of medical research · doi:10.1186/s40001-025-03824-5 · Cited by 4
“Around 17% of obese individuals are insulin sensitive—a phenotype known as metabolically healthy obesity—highlighting the limits of using weight-based measures alone [12].”
Kiran, M., Xie, Y., Ball, G., Anjum, N., Schutte, R., & Pierscionek, B. K. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1714545 · Cited by 5
“Overweight individuals (BMI 25–29.9 kg/m 2 ) exhibited a 51% lower hazard compared with the normal-weight reference group, a counterintuitive pattern sometimes described as the “metabolically healthy overweight” phenomenon (62).”
InfluentialWaist Circumference as a Predictor of Hepatic Steatosis and Fibrosis in the NHANES 2017–2018 Cohort
Janakiram, N., Puri, S., & Thirumalai, A. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261419363 · Cited by 3
“10,11 Indeed, most recently, anthropometric measurements such as WC to con-fi rm the presence of excess adiposity have been added to the de fi nition and diagnostic criteria for clinical obesity.”
Agbaje, A. O. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101437 · Cited by 3
“The diagnostic criterion for MHO is BMI ≥ 30 kg/m 2 and absence of dyslipidemia, hypertension, and/or dysglycemia [63].”
InfluentialPiroș, T., Lupușoru, R., Moleriu, L. C., Muntean, C., Moleriu, R. D., Cîmpian, D. M., Cincu, M.-G., Strete, E. G., Timofte, A. G., & Marin, R.-C. (2026) · Nutrients · doi:10.3390/nu18060977 · Cited by 4
Lipolysis in Health and Disease: Pathways, Regulation, and Metabolic Consequences
Bordelon, C. L., & Stephens, J. M. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01624-7 · Cited by 7
“Although increased fat mass defines obesity, only a subset of individuals with obesity display dysregulated lipolysis [4].”
InfluentialPerspectives on human adipose tissue: from cellular mechanisms to clinical complications
Rydén, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06735-0 · Cited by 5
“The concept of metabolically healthy obesity (MHO) illustrates that excess adiposity per se does not inevitably translate into insulin resistance or cardiovascular risk [5].”
Metabolomic and lifestyle profiles refine BMI-metabolic phenotypes in older adults
Chen, Y., Huang, H., Xu, W., Zhang, W., Wang, Y., Cao, L., Zhao, H., Zhang, Z., Xu, Y., Yuan, A., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102907 · Cited by 3
Is epiploic fat the dermal fat of the intestine?
Onogi, Y., & Ussar, S. (2021) · Gut · doi:10.1136/gutjnl-2021-326073 · Cited by 3
Scaffidi, C., Srdic, A., Konrad, D., & Wueest, S. (2023) · Adipocyte · doi:10.1080/21623945.2023.2276346 · Cited by 5
“Importantly, a better understanding of pathways stimulating energy storage in WAT is of interest, since the development of non-alcoholic fatty liver disease (NAFLD) may be caused by constrained lipid storage in WAT leading to systemic lipid overflow and, consecutively, fatty liver disease [26,27].”
BackgroundPokrovskaya, E. V., Shestakova, E. A., & Shestakova, M. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13088 · Cited by 4
Lentejas, J. P. R., Sandoval, M. A., Evangelista, T. J. P., Buenaluz‐Sedurante, M., & Velayo, C. L. (2023) · Acta Medica Philippina · doi:10.47895/amp.vi0.7315 · Cited by 5
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome
Warmbrunn, M. V., Bahrar, H., de Clercq, N. C., Koopen, A. M., de Groot, P. F., Rutten, J. H. W., Joosten, L. A. B., Kootte, R. S., Bouter, K. E. C., ter Horst, K. W., et al. (2024) · Nutrients · doi:10.3390/nu16121822 · Cited by 4
“However, up to 30% of individuals with obesity do not seem to develop metabolic perturbations, as seen in MetSyn and the concept of metabolically healthy obesity has previously been postulated [12].”
BackgroundPalmieri, F., Akhtar, N. F., Pané, A., Jiménez, A., Olbeyra, R. P., Viaplana, J., Vidal, J., de Hollanda, A., Gama-Pérez, P., Jiménez‐Chillarón, J. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68269-y · Cited by 6
Golubkina, E. O., & Tykhonova, T. M. (2024) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2024-49-12 · Cited by 4
Methoden zur Abschätzung der Insulinresistenz
Blüher, M. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-1780-4148 · Cited by 3
Self-citationPiana, K., Ziomber-Lisiak, A., Ruszczycki, B., Bugajski, A. J., & Szczerbowska‐Boruchowska, M. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110325 · Cited by 3
Fallah, F., & Mahdavi, R. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10460-2 · Cited by 4
“…healthy obesity (MHO), addressed as a transient state to unhealthy phenotype (metabolically unhealthy obesity (MUO)) due to developing cardiometabolic comorbidities overtime [14], represents a subgroup of individuals with obesity devoid of typical obesity-associated metabolic abnormalities [15].”
Distinct T Cell Subset Profiles and T-Cell Receptor Signatures in Metabolically Unhealthy Obesity
Chung, Y., Chang, J., Soedono, S., Julietta, V., Joo, E. J., Kwon, S. H., Choi, S. I., Kim, Y. J., & Cho, K. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073372 · Cited by 4
Cho, I., Lee, S., & Pyun, W. B. (2025) · Cardiorenal Medicine · doi:10.1159/000545802 · Cited by 4
Zhang, B., Zhu, C., Ma, L., Shen, B., & Zhang, G. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1590979 · Cited by 3
Fit-Fat Index and the risk of sudden cardiac death in Finnish men
Isiozor, N. M., Kunutsor, S. K., Kurl, S., Savonen, K. P., Kauhanen, J., & Laukkanen, J. A. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.08.007 · Cited by 4
Metabolically healthy status in childhood obesity fails to protect against vitamin B12 deficiency
Bilici, M. E., & Örnek, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-25029-w · Cited by 4
“The literature suggests that MHO individuals have less visceral and hepatic fat accumulation, greater lower extremity adipose tissue development, preserved subcutaneous fat expandability, better beta-cell function, and higher insulin sensitivity 11–16 .”
Metabolically healthy obesity: prevalence, phenotype characteristic, effectiveness of weight loss
Ostrovskaya, Е. V., Romantsova, T. I., Gerasimov, A. N., & Novoselova, Т. Е. (2020) · Russian Open Medical Journal · doi:10.15275/rusomj.2020.0301 · Cited by 3
Metabolically healthy obesity in a paediatric obesity clinic
Teixeira, D., Martins, C., Oliveira, G., & Soares, R. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0086 · Cited by 3
Yu, M., Zhang, S., Wang, L., Feng, H., Li, X., Wu, J., & Yuan, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811764 · Cited by 3
“Nevertheless, not all individuals with obesity develop metabolic abnormalities, and this group has been referred to as “metabolically healthy obesity (MHO)” [8].”
BackgroundPan, J. H., Wang, Z., Dong, C., Yang, B., Tang, L., Jia, P., Yang, S., & Zeng, H. (2022) · BMC Public Health · doi:10.1186/s12889-022-14253-y · Cited by 3
“However, only 10-30% of obese individuals are reported to be metabolically healthy [11].”
BackgroundПостоева, А. В., Dvoryashina, I. V., Kudryavtsev, A. V., & Александрович, П. В. (2023) · Obesity and metabolism · doi:10.14341/omet12926 · Cited by 3
Metadata
- Authors
- Blüher, M.
- Affiliations
- Helmholtz Munich (DE)
- Corresponding author
- Blüher, Matthias
- ORCID
- Blüher, Matthias
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-03-04
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7098708
- OpenAlex
- W3009496837
- Cited by
- 1,090
- References
- 123
- Citations by year
- 2026: 197 · 2025: 222 · 2024: 213 · 2023: 162 · 2022: 155 · 2021: 105 · 2020: 35
- FWCI
- 86.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (209933838)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- metabolically healthy obesity, obesity, cardiometabolic risk, type 2 diabetes, cardiovascular disease, insulin sensitivity, beta-cell function, ectopic fat, visceral fat, liver fat, leg fat, cardiorespiratory fitness, weight loss, obesity treatment, risk stratification
- MeSH terms
- Obesity, Metabolically Benign, Cardiometabolic Risk Factors, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.